Thar Pharmaceuticals' Series A - II Round

Thar Pharmaceuticals raised a round of funding on January 14, 2011.

Thar Pharmaceuticals is a clinical stage biopharmaceutical company that focuses on developing and commercializing a pipeline of oral therapies for serious and life-threatening conditions. The company'…

Articles about Thar Pharmaceuticals' Series A - II Round: